Testosterone and type 2 diabetes in men

被引：21
|
作者：
Mazur, Allan [1 ]
Westerman, Ronny [2 ]
Werdecker, Andrea [2 ]
Mueller, Ulrich [2 ]
机构：
[1] Syracuse Univ, Maxwell Sch, Syracuse, NY 13244 USA
[2] Univ Marburg, Inst Med Sociol, Marburg, Germany
来源：
AGING MALE | 2014年 / 17卷 / 01期
关键词：
Aging; fasting glucose; obesity; testosterone; Type; 2; diabetes; HORMONE-BINDING GLOBULIN; METABOLIC SYNDROME; INCREASED RISK; HEALTH; DEFICIENCY; MORTALITY;
D O I：
10.3109/13685538.2013.879113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: To assess from observational data if low testosterone in men is an independent risk factor for high fasting glucose (FG) and for a diagnosis of type 2 diabetes (T2D). Methods: Multivariate analysis of data from 991 male US Air Force veterans who completed six medical examinations over 20 years. Results: Low testosterone was moderately related to high FG, independent of age and obesity. Low testosterone is a very weak predictor of a diagnosis of T2D. Conclusions: In men, low testosterone is an independent risk factor for high FG, comparable to aging and obesity. Low testosterone is a weak predictor of a diagnosis of T2D.
引用
收藏
页码：18 / 24
页数：7
相关论文
共 50 条
  • [21] Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications
    Beatrice, Anne M.
    Dutta, Deep
    Kumar, Manoj
    Shivaprasad, Kumbenahalli Siddegowda
    Sinha, Ankur
    Ray, Sayantan
    Chowdhury, Subhankar
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 481 - 486
  • [22] Variation on in Serum Total Testosterone Levels in Men with Type 2 Diabetes Mellitus
    Trivedi, Jyoti
    Kapoor, Sangeeta
    Arora, Rahul
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (06) : BC9 - BC11
  • [23] Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations
    Ross Apostolov
    Emily Gianatti
    Darren Wong
    Numan Kutaiba
    Paul Gow
    Mathis Grossmann
    Marie Sinclair
    World Journal of Hepatology, 2022, 14 (04) : 754 - 765
  • [24] Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome
    Hackett, Geoffrey
    SEXUAL MEDICINE REVIEWS, 2019, 7 (03) : 476 - 490
  • [25] Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations
    Apostolov, Ross
    Gianatti, Emily
    Wong, Darren
    Kutaiba, Numan
    Gow, Paul
    Grossmann, Mathis
    Sinclair, Marie
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (04) : 754 - U128
  • [26] Normalization of testosterone levels enhances the favorable effects of exercise and diet in men with diabetes type 2 with subnormal testosterone
    Saad, Farid
    Heufelder, Armin
    Gooren, Louis
    JOURNAL OF ANDROLOGY, 2008, : 54 - 54
  • [27] EVALUATION OF THE EFFECT OF TESTOSTERONE REPLACEMENT THERAPY WITH A TRANSDERMAL TESTOSTERONE ON GLYCEMIC CONTROL IN MEN WITH TYPE 2 DIABETES MELLITUS
    Rozhivanov, Roman V.
    Chernova, Mariia O.
    Ioutsi, Vitaly A.
    Mel'nichenko, Galina A.
    Shestakova, Marina V.
    Rozhivanova, Ekaterina R.
    Andreeva, Elena N.
    Mokrysheva, Natalya G.
    DIABETES MELLITUS, 2024, 27 (02): : 120 - 129
  • [28] Statin use is associated with lower total testosterone levels but not bioavailable or free testosterone in men with Type 2 diabetes
    Stanworth, R. D.
    Kapoor, D.
    Channer, K. S.
    Jones, T. H.
    DIABETIC MEDICINE, 2007, 24 : 69 - 69
  • [29] Testosterone replacement therapy could improve survival in men with both low levels of testosterone and type 2 diabetes
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 673 - 673
  • [30] Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes
    Muraleedharan, Vakkat
    Marsh, Hazel
    Kapoor, Dheeraj
    Channer, Kevin S.
    Jones, T. Hugh
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 169 (06) : 725 - 733
12345